chr21-34449462-G-A

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 1P and 0B. PP5

The NM_000219.6(KCNE1):​c.173C>T​(p.Thr58Ile) variant causes a missense change. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T58S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0 ( 0 hom., cov: 17)
Exomes 𝑓: 0.0000053 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

KCNE1
NM_000219.6 missense

Scores

3
11
5

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:2U:4

Conservation

PhyloP100: 6.68

Publications

2 publications found
Variant links:
Genes affected
KCNE1 (HGNC:6240): (potassium voltage-gated channel subfamily E regulatory subunit 1) The product of this gene belongs to the potassium channel KCNE family. Potassium ion channels are essential to many cellular functions and show a high degree of diversity, varying in their electrophysiologic and pharmacologic properties. This gene encodes a transmembrane protein known to associate with the product of the KVLQT1 gene to form the delayed rectifier potassium channel. Mutation in this gene are associated with both Jervell and Lange-Nielsen and Romano-Ward forms of long-QT syndrome. Alternatively spliced transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008]
KCNE1 Gene-Disease associations (from GenCC):
  • long QT syndrome 5
    Inheritance: AD Classification: DEFINITIVE, STRONG, LIMITED Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Jervell and Lange-Nielsen syndrome 2
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
  • Jervell and Lange-Nielsen syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • atrial fibrillation
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PP5
Variant 21-34449462-G-A is Pathogenic according to our data. Variant chr21-34449462-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 372392.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNE1NM_000219.6 linkc.173C>T p.Thr58Ile missense_variant Exon 4 of 4 ENST00000399286.3 NP_000210.2 P15382C7S316Q6FHJ6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNE1ENST00000399286.3 linkc.173C>T p.Thr58Ile missense_variant Exon 4 of 4 1 NM_000219.6 ENSP00000382226.2 P15382

Frequencies

GnomAD3 genomes
AF:
0.00
AC:
0
AN:
115418
Hom.:
0
Cov.:
17
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000278
AC:
7
AN:
251410
AF XY:
0.0000147
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000202
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00000526
AC:
6
AN:
1141764
Hom.:
0
Cov.:
20
AF XY:
0.00000346
AC XY:
2
AN XY:
578700
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
26450
American (AMR)
AF:
0.000120
AC:
5
AN:
41746
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23652
East Asian (EAS)
AF:
0.0000272
AC:
1
AN:
36738
South Asian (SAS)
AF:
0.00
AC:
0
AN:
77430
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51820
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5252
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
828960
Other (OTH)
AF:
0.00
AC:
0
AN:
49716
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.0772119), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.392
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
115418
Hom.:
0
Cov.:
17
AF XY:
0.00
AC XY:
0
AN XY:
55534
African (AFR)
AF:
0.00
AC:
0
AN:
30202
American (AMR)
AF:
0.00
AC:
0
AN:
11568
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2658
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3526
South Asian (SAS)
AF:
0.00
AC:
0
AN:
3278
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8386
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
244
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53362
Other (OTH)
AF:
0.00
AC:
0
AN:
1546
Alfa
AF:
0.00
Hom.:
0
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Pathogenic:1
Aug 16, 2016
GeneDx
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The T58I variant that is likely pathogenic was identified in the KCNE1 gene. It has not beenpublished as a pathogenic variant, nor has it been reported as a benign variant to our knowledge.However, this variant has been reported in one other individual referred for LQTS genetic testing atGeneDx. The T58I variant was not observed in approximately 6,500 individuals of European andAfrican American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a commonbenign variant in these populations. The T58I variant is a non-conservative amino acid substitution,which is likely to impact secondary protein structure as these residues differ in polarity, charge, sizeand/or other properties, and this substitution occurs at a position that is conserved across species. Alikely pathogenic variant at the same residue (T58P) has been reported in the Human Gene MutationDatabase in association with LQTS (Stenson et al., 2014), supporting the functional importance ofthis residue. Furthermore, functional studies of the KCNE1 gene by Melman et al. (2002) concludedthat T58, the central amino acid of a triplet responsible for the specificity of KCNE1 control ofactivation of the potassium channel, is essential for the specific control of voltage-dependent channelactivation characteristics. However, in silico analysis is inconsistent in its predictions as to whether ornot the variant is damaging to the protein structure/function. Therefore, this variant is likely pathogenic. -

Primary dilated cardiomyopathy Pathogenic:1
Aug 29, 2017
Center for Advanced Laboratory Medicine, UC San Diego Health, University of California San Diego
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1
May 02, 2019
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The KCNE1 c.173C>T; p.Thr58Ile variant (rs747321794) is reported in the literature in at least one individual affected with long QT syndrome (Faridi 2019). Additionally, another variant at this codon (c.172A>C; p.Thr58Pro) has been reported in individuals with long QT syndrome (Kapplinger 2009). The p.Thr58Ile variant is reported in ClinVar (Variation ID: 372392), and is found in the Latino population with an allele frequency of 0.023% (8/35,440 alleles) in the Genome Aggregation Database. The threonine at codon 58 is highly conserved, and computational analyses (SIFT: tolerated, PolyPhen-2: probably damaging) predict conflicting effects of this variant on protein structure/function. However, functional analyses of the KCNE1 protein show that threonine 58 is critical for specific control of the voltage-dependent potassium channel, and that the p.Thr58Ile variant results in voltage-independent activation in vitro (Melman 2002). Due to limited information, the clinical significance of the p.Thr58Ile variant is uncertain at this time. References: Faridi R et al. Mutational and phenotypic spectra of KCNE1 deficiency in Jervell and Lange-Nielsen Syndrome and Romano-Ward Syndrome. Hum Mutat. 2019 Feb;40(2):162-176. Kapplinger JD et al. Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm. 2009 Sep;6(9):1297-303. Melman YF et al. A single transmembrane site in the KCNE-encoded proteins controls the specificity of KvLQT1 channel gating. J Biol Chem. 2002 Jul 12;277(28):25187-94. -

SUDDEN INFANT DEATH SYNDROME Uncertain:1
Oct 01, 2021
Robert's Program, Boston Children's Hospital
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

We classify this variant as a variant of uncertain significance using ACMG/AMP criteria. As this variant has functional evidence supporting pathogenicty, we suspect this variant is favoring pathogenic. -

Long QT syndrome Uncertain:1
Oct 24, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 58 of the KCNE1 protein (p.Thr58Ile). This variant is present in population databases (rs747321794, gnomAD 0.02%). This missense change has been observed in individual(s) with clinical features of long QT syndrome (PMID: 30461122). ClinVar contains an entry for this variant (Variation ID: 372392). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on KCNE1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Cardiovascular phenotype Uncertain:1
Aug 08, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.T58I variant (also known as c.173C>T), located in coding exon 1 of the KCNE1 gene, results from a C to T substitution at nucleotide position 173. The threonine at codon 58 is replaced by isoleucine, an amino acid with similar properties. This alteration has been reported in a long QT syndrome cohort and a sudden unexplained death cohort; however, clinical details were limited in both cases (Faridi R et al. Hum Mutat, 2019 Feb;40:162-176; Koh HY et al. Genet Med, 2022 Apr;24:839-850). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.78
BayesDel_addAF
Uncertain
0.16
D
BayesDel_noAF
Pathogenic
0.34
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.56
D;D;D;D;D;D;D;D
Eigen
Uncertain
0.64
Eigen_PC
Uncertain
0.64
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Benign
0.83
.;.;T;.;.;.;.;.
M_CAP
Uncertain
0.12
D
MetaRNN
Uncertain
0.59
D;D;D;D;D;D;D;D
MetaSVM
Uncertain
0.71
D
MutationAssessor
Uncertain
2.8
M;M;M;M;M;M;M;M
PhyloP100
6.7
PrimateAI
Uncertain
0.71
T
PROVEAN
Benign
-1.2
N;.;.;N;N;N;N;N
REVEL
Uncertain
0.55
Sift
Benign
0.20
T;.;.;T;T;T;T;T
Sift4G
Benign
0.12
T;T;T;T;T;T;T;T
Polyphen
1.0
D;D;D;D;D;D;D;D
Vest4
0.62
MutPred
0.25
Loss of sheet (P = 0.0181);Loss of sheet (P = 0.0181);Loss of sheet (P = 0.0181);Loss of sheet (P = 0.0181);Loss of sheet (P = 0.0181);Loss of sheet (P = 0.0181);Loss of sheet (P = 0.0181);Loss of sheet (P = 0.0181);
MVP
0.93
MPC
0.45
ClinPred
0.89
D
GERP RS
5.2
Varity_R
0.34
gMVP
0.88
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs747321794; hg19: chr21-35821760; COSMIC: COSV61607919; API